849767-21-1 Usage
General Description
1-BOC-3-[(1,1-Dimethylethyl)dimethylsilyloxy methyl]-piperidin-4-one, also known as Boc-piperidone, is a chemical compound commonly used in organic synthesis and pharmaceutical research. It is a derivative of piperidone, a heterocyclic organic compound, and contains a tertiary butyl carbamate (Boc) protecting group, as well as a silyl ether functional group. 1-BOC-3-[(1,1-DIMETHYLETHYL)DIMETHYLSILYLOXYMETHYL]-PIPERIDIN-4-ONE is often used as a key intermediate in the synthesis of various drugs and pharmaceutical compounds due to its stability and reactivity. Boc-piperidone is also used in the synthesis of other important chemicals, such as ligands and biologically active molecules, making it a valuable reagent in chemical research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 849767-21-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,9,7,6 and 7 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 849767-21:
(8*8)+(7*4)+(6*9)+(5*7)+(4*6)+(3*7)+(2*2)+(1*1)=231
231 % 10 = 1
So 849767-21-1 is a valid CAS Registry Number.
849767-21-1Relevant articles and documents
CHEMOKINE RECEPTOR MODULATORS AND USES THEREOF
-
, (2018/05/03)
Disclosed herein, inter alia, are compounds and methods of use thereof for the modulation of chemokine receptor activity.
FUSED PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS
-
, (2015/02/02)
The invention relates to fused piperidine amides useful as inhibitors of ion channels for the treatment of pain. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
Piperdine derivatives useful as CCR3 antagonists
-
Page/Page column 19, (2008/06/13)
The use of CCR3 antagonists of the formula I or a pharmaceutically acceptable salt thereof for the treatment of asthma is disclosed, as well as novel compounds of the formula II, pharmaceutical compositions comprising them, and their use in the treatment